Page 24 - Demo

Chapter 122References 1. Janicki MP, Henderson CM, Rubin IL. Neurodevelopmental conditions and aging: Report on the Atlanta Study Group Charrette on Neurodevelopmental Conditions and Aging*. Disability and Health Journal. 2008/04/01/ 2008;1(2):116-124. doi:https://doi.org/10.1016/j.dhjo.2008.02.0042. de Graaf G, Buckley F, Skotko BG. Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United States. Am J Med Genet A. Apr 2015;167a(4):756-67. doi:10.1002/ajmg.a.370013. Moliner AM, Waligora J. The European Union Policy in the Field of Rare Diseases. Adv Exp Med Biol. 2017;1031:561-587. doi:10.1007/978-3-319-67144-4_304. Blagojevic C, Heung T, Theriault M, et al. Estimate of the contemporary live-birth prevalence of recurrent 22q11.2 deletions: a cross-sectional analysis from population-based newborn screening. CMAJ Open. Jul-Sep 2021;9(3):E802-e809. doi:10.9778/cmajo.202002945. Petriti U, Dudman DC, Scosyrev E, Lopez-Leon S. Global prevalence of Rett syndrome: systematic review and meta-analysis. Syst Rev. Jan 16 2023;12(1):5. doi:10.1186/s13643-023-02169-66. van Eeghen AM, Bruining H, Wolf NI, et al. Personalized medicine for rare neurogenetic disorders: can we make it happen? Cold Spring Harb Mol Case Stud. Feb 2022;8(2)doi:10.1101/mcs.a0062007. Morris-Rosendahl DJ, Crocq MA. Neurodevelopmental disorders-the history and future of a diagnostic concept . Dialogues Clin Neurosci. Mar 2020;22(1):65-72. doi:10.31887/DCNS.2020.22.1/macrocq8. Schalock RL, Luckasson R, Tassé MJ. An Overview of Intellectual Disability: Definition,Diagnosis, Classification, and Systems of Supports (12th ed.). Am J Intellect Dev Disabil. Nov 1 2021;126(6):439-442. doi:10.1352/1944-7558-126.6.4399. Hickman RA, O’Shea SA, Mehler MF, Chung WK. Neurogenetic disorders across the lifespan: from aberrant development to degeneration. Nat Rev Neurol. Feb 2022;18(2):117-124. doi:10.1038/s41582-021-00595-510. Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M. Alzheimer’s diseaseassociated with Down syndrome: a genetic form of dementia. Lancet Neurol. Nov 2021;20(11):930-942. doi:10.1016/s1474-4422(21)00245-311. Picciotti PM, Carfì A, Anzivino R, et al. Audiologic Assessment in Adults With Down Syndrome. Am J Intellect Dev Disabil. Jul 2017;122(4):333-341. doi:10.1352/1944-7558-122.4.33312. Bonnard Å, Hederstierna C, Bark R, Hultcrantz M. Audiometric features in young adults with Turner syndrome. Int J Audiol. Sep 2017;56(9):650-656. doi:10.1080/14992027.2017.131455913. Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. Nov 2014;29(13):1583-90. doi:10.1002/mds.2594514. Boot E, Butcher NJ, Udow S, et al. Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2. Neurology. Jun 5 2018;90(23):e2059-e2067. doi:10.1212/wnl.000000000000566015. McDonald-McGinn DM, Sullivan KE, Marino B, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers. Nov 19 2015;1:15071. doi:10.1038/nrdp.2015.7116. McDonald-McGinn DM, Tonnesen MK, Laufer-Cahana A, et al. Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genet Med. Jan-Feb 2001;3(1):23-9. doi:10.1097/00125817-200101000-0000617. Babcock M, Pavlicek A, Spiteri E, et al. Shuffling of genes within low-copy repeats on22q11 (LCR22) by Alu-mediated recombination events during evolution. Genome Res. Dec 2003;13(12):2519-32. doi:10.1101/gr.154950318. Du Q, de la Morena MT, van Oers NSC. The Genetics and Epigenetics of 22q11.2 Deletion Syndrome. Front Genet. 2019;10:1365. doi:10.3389/fgene.2019.01365